New Findings for 1999 (click on link for summary and article link)
Clinical Observations and Diagnosis
1.1 "Epidemiologic and Clinical Aspects of the Ebola Virus Epidemic in
Mosango, Democratic Republic of the Congo, 1995"
1.2 "Ebola Hemorrhagic Fever in Kitwit, Democratic Republic of the Congo:
Clinical Observations in 103 Patients"
1.3 "Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995:
Determinants of Survival"
1.4 "Human Infection Due to Ebola Virus, Subtype Cote d'Ivoire: Clinical and
Biologic Presentation"
Viral Surveillance and Epidemiology
2.1 "The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the
Congo, 1995"
2.2 "Epidemiology of Ebola (Subtype Reston) Virus in the Philippines, 1996"
2.3 "Ebola Hemorrhagic Fever Outbreaks in Gabon, 1994-1997: Epidemiologic and
Health Control Issues"
Pathogenesis and Clinical Virology
3.1 "Ebola Virus Secretroy Glycoprotein (sGP) Diminishes Fc gamma RIIIB-to-CR3
Proximity on Neutrophils"
3.2 "Markedly Elevated Levels of Interferon (IFN)-gamme, IFN-alpha,
Interleukin (IL)-2, IL-10, and Tumor Necrosis Factor-alpha Associated
With Fatal Ebola Virus Infection"
3.3 "Clinical Virology of Ebola Hemorrhagic Fever (EHF): Virus, Virus Antigen,
and IgG and IgM Antibody Findings among EHF Patients in Kikwit,
Democratic Republic of the Congo, 1995"
3.4 "Ebola Virus Selectively Inhibits Responses to Interferons, but Not to
Interleukin-1 beta, in Endothelial Cells"
3.5 "LearnCoil-VMF: Computational Evidence for Coiled-coil-like Motifs in Many
Viral Membrance-fusion Proteins"
Experimental Therapies, Prophylaxis, Vaccines
4.1 "Ebola Virus Can Be Effectively Neutralized by Antibody Produced in
Natural Human Infection"
4.2 "Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by
immunization with liposomes containing lipid A"
4.3 "Preparations and Use of Hyperimmune Serum for Prophylaxis and Therapy of
Ebola Virus Infections"
4.4 "Recombinant Human Monoclonal Antibodies to Ebola Virus"
4.5 "Antiviral Drug Therapy of Filovirus Infections: S-Adenosylhomocysteine
Hydrolase Inhibitors Inhibit Ebola Virus In Vitro and in a Lethal Mouse
Model"
4.6 "Evaluation of Immune Globulin and Recombinant Interferon-alpha2b for
Treatment of Experimental Ebola Virus Infections"
Viral Control, Response, and Prevention
5.1 "Ebola Outbreaks in Kikwit, Democratic Republic of the Congo: Discovery
and Control Measures"
5.2 "Unsafe injections in the developing world and transmission of bloodborne
pathogens: a review"
5.3 "Long-Term Disease Surveillance in Bandundu Region, Democratic Republic of
the Congo: A Model for Early Detection and Prevention of Ebola
Hemorrhagic Fever"
5.4 "Interventions to Control Virus Transmission during an Outbreak of Ebola
Hemorrhagic Fever: Experience from Kikwit, Democratic Republic of the
Congo, 1995"
Lessons and Future Research
6.1"Ecology of Marbury and Ebola Viruses: Speculations and Directions for
Future Research"
6.2 "Gleanings from the Harvest: Suggestions for Priority Actions against
Ebola Virus Epidemics"
6.3 "An outbreak of Ebola virus: Lessons for everyday activities in the
intensive care unit"
6.4 "Ebola Hemorrhagic Fever: Lessons from Kikwit, Democratic Republic of the
Congo"